Mangrove Partners Cortexyme, Inc. Transaction History

Mangrove Partners

$778 Million
Q3 2025

A detailed history of Mangrove Partners transactions in Cortexyme, Inc. stock. As of the latest transaction made, Mangrove Partners holds 11,000 shares of CRTX stock, worth $14,190. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,000

Holding current value

$14,190

% of portfolio

0.01%

0 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form

No transaction found.

Others Institutions Holding CRTX

# of Institutions

Shares Held

12.6M

Call Options Held

98.3K

Put Options Held

Nantahala Capital Management, LLC New Canaan, CT

3.07M
Shares

$3.97 Million
0.16% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$2.27 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.39M
Shares

$1.79 Million
0.0% of portfolio
Ieq Capital, LLC

981K
Shares

$1.27 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

825K
Shares

$1.06 Million
0.31% of portfolio

View Full List

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Account